That study also showed that the inhibition of C5a with NOX-D21 reduced adipose differentiation-related protein (ADRP) in the diabetic kidney as well as the expression of Dgat1 and Srebp-1, suggesting a role for C5a/C5aR1 in renal lipid metabolism (164). This evidence concerns the gene C5 and medical procedure.